Physician profile
Hadi R Najafian
NPI 1922136928
$1,579,027.58
in general payments reported to CMS, 2019-2025
20 companies · $184K in 2025
The $184K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270K · 2020: $157K · 2021: $309K · 2022: $231K · 2023: $216K · 2024: $212K · 2025: $184K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $454K · Travel and Lodging: $121K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $17K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $453,510.77 |
| Travel and Lodging | $121,112.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,000.00 |
| Food and Beverage | $17,420.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,577,691.39 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Merck Sharp & Dohme LLC | $384.79 | 2020-2024 | Bridion, Dificid |
| Medtronic, INC. | $271.44 | 2021-2025 | Interstim |
| Davol INC. | $198.80 | 2019-2020 | |
| Baxter Healthcare | $44.71 | 2022 | |
| Coloplast Corp | $43.85 | 2019-2022 | |
| Axonics, INC. | $42.99 | 2022 | |
| Ethicon US, LLC | $42.34 | 2021-2022 | |
| Acell, INC. | $42.06 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.16 | 2021-2024 | Xifaxan |
| Innovation Technologies INC | $36.95 | 2022-2024 | Irrisept |
| Acacia Pharma INC | $36.77 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.40 | 2022 | |
| Orphalan INC | $21.54 | 2024 | Cuvrior |
| Avanos Medical | $19.01 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.57 | 2019 | |
| Tei Biosciences INC | $17.74 | 2019 | |
| Innocoll Pharmaceuticals Limited | $15.56 | 2021 | |
| Advanced Oxygen Therapy INC. | $15.31 | 2024 | Topical Oxygen Chamber For Extremities |
| Braintree Laboratories, INC. | $13.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hadi Najafian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.